CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 6 Months Ended |
Sep. 30, 2023 | Sep. 30, 2022 |
Cash flows from operating activities: | | |
Net income (loss) | $ 854,807 | $ 3,119,392 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (1,017,868) | (3,235,667) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 2,828 | (198) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 1 |
(Decrease) Increase in accounts payable affiliates | (965,676) | (1,418,723) |
Net cash (used in) provided by operating activities | (1,125,909) | (1,535,195) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 1,017,083 | 3,235,667 |
Net cash provided by investing activities | 1,017,083 | 3,235,667 |
Cash flows from financing activities: | | |
Distributions | 0 | (2,957,455) |
Net cash used in financing activities | 0 | (2,957,455) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (108,826) | (1,256,983) |
Cash and cash equivalents, beginning | 508,245 | 2,370,898 |
Cash and cash equivalents, ending | 399,419 | 1,113,915 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 2,706,879 | 0 |
Series 20 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 21 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 22 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 23 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 24 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 25 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 26 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 27 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 28 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 29 | | |
Cash flows from operating activities: | | |
Net income (loss) | 357,480 | (43,188) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (430,628) | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 2,582 | (28) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | (406,423) | 2,256 |
Net cash (used in) provided by operating activities | (476,989) | (40,960) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 429,843 | 0 |
Net cash provided by investing activities | 429,843 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (47,146) | (40,960) |
Cash and cash equivalents, beginning | 47,146 | 108,768 |
Cash and cash equivalents, ending | 0 | 67,808 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 2,706,879 | 0 |
Series 30 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 31 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 32 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 33 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 34 | | |
Cash flows from operating activities: | | |
Net income (loss) | (59,482) | (39,140) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 54 | (28) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 29,246 | 9,246 |
Net cash (used in) provided by operating activities | (30,182) | (29,922) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (30,182) | (29,922) |
Cash and cash equivalents, beginning | 31,891 | 81,705 |
Cash and cash equivalents, ending | 1,709 | 51,783 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 35 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 36 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 37 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 38 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 39 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 40 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 41 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 42 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 43 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 44 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 1,755,220 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (1,746,178) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (28,269) |
Net cash (used in) provided by operating activities | 0 | (19,227) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 1,746,178 |
Net cash provided by investing activities | 0 | 1,746,178 |
Cash flows from financing activities: | | |
Distributions | 0 | (2,957,455) |
Net cash used in financing activities | 0 | (2,957,455) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (1,230,504) |
Cash and cash equivalents, beginning | 0 | 1,230,504 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 45 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 1,420,329 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (1,410,868) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | (29) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (1,130,104) |
Net cash (used in) provided by operating activities | 0 | (1,120,672) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 1,410,868 |
Net cash provided by investing activities | 0 | 1,410,868 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 290,196 |
Cash and cash equivalents, beginning | 0 | 287,530 |
Cash and cash equivalents, ending | 0 | 577,726 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 46 | | |
Cash flows from operating activities: | | |
Net income (loss) | 556,809 | 26,171 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (587,240) | (78,621) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 192 | (113) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 1 |
(Decrease) Increase in accounts payable affiliates | (588,499) | (271,852) |
Net cash (used in) provided by operating activities | (618,738) | (324,414) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 587,240 | 78,621 |
Net cash provided by investing activities | 587,240 | 78,621 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (31,498) | (245,793) |
Cash and cash equivalents, beginning | 429,208 | 662,391 |
Cash and cash equivalents, ending | 397,710 | 416,598 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | $ 0 | $ 0 |